This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Indexing of Reports on Aripiprazole Augmentation of Clozapine

Adam Keller Ashton, MD

Published: February 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: I read with interest 2 letters published in the April 2006 issue, "High-Dose Aripiprazole in Treatment-Resistant Schizophrenia"1 and "Clozapine Augmentation With Aripiprazole for Negative Symptoms."2 The first letter states, "Comparatively little information is available regarding the use of aripiprazole at doses higher than 30 mg/day."1(p675) The authors of the second letter state, "We found no published reports on the use of aripiprazole as an augmentation agent to clozapine."2(p675)‘ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...